Aspreva Pharmaceuticals
Latest round
- Series A
Last raised
- Mar 2004
Total raised
- $53M
Investors
- 7
About Aspreva Pharmaceuticals
Aspreva Pharmaceuticals is dedicated to developing treatments for rare diseases. The company was headquartered in Victoria, Canada, and has made strides since its inception.20 mn. In December 2007, the company was acquired by Galenica.Aspreva Pharmaceuticals primarily focuses on innovative pharmaceutical solutions for rare diseases. Its leading product provides targeted therapies that enhance quality of life for patients with specific medical conditions. The company serves a diverse range of clients, including healthcare providers and research organizations, who utilize these solutions to better manage rare diseases and improve patient outcomes.The company generates revenue through the sale of its pharmaceutical products, following a direct sales model that connects it with healthcare providers and facilities. Revenue is supplemented through strategic partnerships, which enhance product distribution and accessibility.Aspreva Pharmaceuticals aims to expand its product line by developing new therapies for additional rare diseases, with several candidates expected to enter clinical trials by 2023. The company plans to penetrate new markets in Europe and Asia, targeting specific regions to enhance accessibility to its treatments by 2024.20 mn will support these initiatives, focusing on research and development as well as market expansion efforts.
Who invested in Aspreva Pharmaceuticals
7 investors across 1 round
See all investors in Aspreva Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 9, 2004
Amount
$53M
Investors
Questions about Aspreva Pharmaceuticals
Who invested in Aspreva Pharmaceuticals?
Aspreva Pharmaceuticals has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aspreva Pharmaceuticals raised?
Aspreva Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aspreva Pharmaceuticals last raise money?
Aspreva Pharmaceuticals's most recent round on record is a Series A, in Mar 2004.
What does Aspreva Pharmaceuticals do?
Aspreva Pharmaceuticals is dedicated to developing treatments for rare diseases.
Where is Aspreva Pharmaceuticals headquartered?
Aspreva Pharmaceuticals is headquartered in Victoria, Canada.
Which VCs invest in companies like Aspreva Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Aspreva Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Aspreva Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.